aidsВИЧ-инфекция и иммуносупрессииHIV Infection and Immunosuppressive Disorders2077-9828Baltic Medical Education Centeraids-780Research ArticleМАТЕРИАЛЫ КОНФЕРЕНЦИИ МОЛОДЫХ УЧЕНЫХ И СПЕЦИАЛИСТОВ «НОВОСТИ ИНФЕКТОЛОГИИ, МИКРОБИОЛОГИИ И БИОТЕХНОЛОГИИ-2022»MATERIALS OF THE CONFERENCE OF YOUNG SCIENTISTS AND SPECIALISTS OF «INFECTOLOGY NEWS, MICROBIOLOGY AND BIOTECHNOLOGY-2022»Характеристика уровня вируснейтрализующих антител к SARS-CoV-2 у больных ВИЧ-инфекцией после COVID-19Characteristics of the level of virus-neutralizing antibodies to SARS-CoV-2 in patients with hiv after COVID-19ПобегаловаО. Е.PobegalovaO. E.
Санкт-Петербург
St. Petersburg
Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. ПавловаРоссияPavlov First State Medical University St. PetersburgRussian Federation2023300420231517374Copyright © Побегалова О.Е., 20232023Побегалова О.Е.Pobegalova O.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://hiv.bmoc-spb.ru/jour/article/view/780
.
.
ReferencesAlrubayyi A., Gea-Mallorquí E., Touizer E. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV // bioRxiv: the preprint server for biology, 2021.02.15.431215. https://doi.org/10.1101/2021.02.15.431215Alrubayyi A., Gea-Mallorquí E., Touizer E. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV // bioRxiv: the preprint server for biology, 2021.02.15.431215. https://doi.org/10.1101/2021.02.15.431215Liu W.D., Hung C.C., Wang J.T. Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 // Journal of the Formosan Medical Association = Taiwan yi zhi. 2021. Vol. 120, No. 12. Р. 2186–2190. https://doi.org/10.1016/j.jfma.2021.04.010.Liu W.D., Hung C.C., Wang J.T. Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 // Journal of the Formosan Medical Association = Taiwan yi zhi. 2021. Vol. 120, No. 12. Р. 2186–2190. https://doi.org/10.1016/j.jfma.2021.04.010.Macías J., Fernández-Fuertes M., Oliver N. Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2022. Vol. 28, No. 5. Р. 755–756. https://doi.org/10.1016/j.cmi.2022.01.028.Macías J., Fernández-Fuertes M., Oliver N. Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2022. Vol. 28, No. 5. Р. 755–756. https://doi.org/10.1016/j.cmi.2022.01.028.
The authors declare that there are no conflicts of interest present.